GlaxoSmithKline Balance Sheet
GlaxoSmithKline's total assets for Q4 2025 were £61.12B, a decrease of -0.36% from the previous quarter. GB:GSK total liabilities were £45.09B for the fiscal quarter, a -1.08% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.